Evidence map›Paper›PMID 31106124›Full record

ArticleTranslational lung cancer research2019

A comparison of

Hanyan Xu, Adam Abdul Hakeem Baidoo, Shanshan Su, Junru Ye, Chengshui Chen, Yupeng Xie, Luca Bertolaccini, Mahmoud Ismail, Biagio Ricciuti, Calvin Sze Hang Ng and 3 more

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Translational lung cancer research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Comparison ofAmerican journal of translational research · 2022
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 5 countries.

Hanyan XuThe Key Laboratory of Interventional Pulmonology of Zhejiang Province, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
Adam Abdul Hakeem BaidooThe Key Laboratory of Interventional Pulmonology of Zhejiang Province, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
Shanshan SuThe Key Laboratory of Interventional Pulmonology of Zhejiang Province, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
Junru YeThe Key Laboratory of Interventional Pulmonology of Zhejiang Province, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
Chengshui ChenThe Key Laboratory of Interventional Pulmonology of Zhejiang Province, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
Yupeng XieThe Key Laboratory of Interventional Pulmonology of Zhejiang Province, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
Luca BertolacciniDepartment of Thoracic Surgery, Maggiore Teaching Hospital, Bologna, Italy.
Mahmoud IsmailDepartment for Thoracic Surgery, Klinikum Ernst von Bergmann, Academic Hospital of the Charité - Universitätsmedizin, Humboldt University Berlin, Berlin, Germany.
Biagio RicciutiMedical Oncology, Santa Maria della Misericordia Hospital, Azienda Ospedaliera di Perugia, Perugia, Italy.
Calvin Sze Hang NgDepartment of Surgery, The Chinese University of Hong Kong, Prince of Wales Hospital, Hong Kong, China.
Raja M FloresDepartment of Thoracic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Yuping LiThe Key Laboratory of Interventional Pulmonology of Zhejiang Province, Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325015, China.
written on behalf of AME Lung Cancer Collaborative Group
Wenzhou Medical University · CNChinese University of Hong Kong · HKHumboldt-Universität zu Berlin · DEOspedale Maggiore Carlo Alberto Pizzardi · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPrevious studies have shown that there are different methods used to detect the epidermal growth factor receptor (

methodsThis prospective cohort study enrolled patients who presented with advanced (stage IIIb/IV) lung adenocarcinoma.

resultsIn total, 203 patients were included in the final analysis. Mutations were discovered in 58.6% (119/203) of the tumor tissues and 31.0% (63/203) were detected

conclusionsUsing ADx-ARMS as an approach with high specificity but moderate sensitivity to detect the

Indexed as

cfDNAEpidermal growth factor receptor (EGFR)lung adenocarcinoma

Identifiers

PMID31106124
PMCPMC6504650
OpenAlexW2938403137

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.